BIP
AMAG

Brandes Investment Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Brandes Investment Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-50,424
Closed -$1.02M – 144
2018
Q1 		$1.02M Buy
+50,424
New +$853K 0.02% 127

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brandes Investment Partners's AMAG Position: Q2 2018 in Review

Brandes Investment Partners sold out of AMAG Pharmaceuticals (AMAG) in Q2 2018, closing a stake of 50,424 shares — an estimated $1.02M sold.

Brandes Investment Partners first reported a position in AMAG in Q1 2018 and held it in 1 quarter. The position peaked at $1.02M in Q1 2018. 173 funds tracked by Wall St. Rank hold AMAG as of Q2 2018.

  • Brandes Investment Partners reported no remaining AMAG Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Brandes Investment Partners sold 50,424 AMAG Pharmaceuticals shares in Q2 2018, an estimated $1.02M.
  • Brandes Investment Partners first reported a position in AMAG Pharmaceuticals in Q1 2018 and held it in 1 quarter.
  • Brandes Investment Partners's AMAG Pharmaceuticals position peaked at $1.02M in Q1 2018.
  • 173 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2018.

Based on Brandes Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.